Your browser doesn't support javascript.
loading
The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma.
Kader, Tanjina; Elder, Kenneth; Zethoven, Magnus; Semple, Timothy; Hill, Prue; Goode, David L; Thio, Niko; Cheasley, Dane; Rowley, Simone M; Byrne, David J; Pang, Jia-Min; Miligy, Islam M; Green, Andrew R; Rakha, Emad A; Fox, Stephen B; Mann, G Bruce; Campbell, Ian G; Gorringe, Kylie L.
Afiliação
  • Kader T; 1Peter MacCallum Cancer Centre, Melbourne, VIC Australia.
  • Elder K; 2The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC Australia.
  • Zethoven M; 3The Breast Service, The Royal Women's Hospital, Fitzroy, VIC Australia.
  • Semple T; 1Peter MacCallum Cancer Centre, Melbourne, VIC Australia.
  • Hill P; 1Peter MacCallum Cancer Centre, Melbourne, VIC Australia.
  • Goode DL; 4Department of Anatomical Pathology, St Vincent's Hospital, Fitzroy, VIC Australia.
  • Thio N; 1Peter MacCallum Cancer Centre, Melbourne, VIC Australia.
  • Cheasley D; 2The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC Australia.
  • Rowley SM; 1Peter MacCallum Cancer Centre, Melbourne, VIC Australia.
  • Byrne DJ; 1Peter MacCallum Cancer Centre, Melbourne, VIC Australia.
  • Pang JM; 1Peter MacCallum Cancer Centre, Melbourne, VIC Australia.
  • Miligy IM; 1Peter MacCallum Cancer Centre, Melbourne, VIC Australia.
  • Green AR; 1Peter MacCallum Cancer Centre, Melbourne, VIC Australia.
  • Rakha EA; 5Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital, Nottingham, UK.
  • Fox SB; 5Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital, Nottingham, UK.
  • Mann GB; 5Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital, Nottingham, UK.
  • Campbell IG; 1Peter MacCallum Cancer Centre, Melbourne, VIC Australia.
  • Gorringe KL; 3The Breast Service, The Royal Women's Hospital, Fitzroy, VIC Australia.
NPJ Breast Cancer ; 6: 9, 2020.
Article em En | MEDLINE | ID: mdl-32195332
Intraductal papillomas (IDP) are challenging breast findings because of their variable risk of progression to malignancy. The molecular events driving IDP development and genomic features of malignant progression are poorly understood. In this study, genome-wide CNA and/or targeted mutation analysis was performed on 44 cases of IDP, of which 20 cases had coexisting ductal carcinoma in situ (DCIS), papillary DCIS or invasive ductal carcinoma (IDC). CNA were rare in pure IDP, but 69% carried an activating PIK3CA mutation. Among the synchronous IDP cases, 55% (11/20) were clonally related to the synchronous DCIS and/or IDC, only one of which had papillary histology. In contrast to pure IDP, PIK3CA mutations were absent from clonal cases. CNAs in any of chromosomes 1, 16 or 11 were significantly enriched in clonal IDP lesions compared to pure and non-clonal IDP. The observation that 55% of IDP are clonal to DCIS/IDC indicates that IDP can be a direct precursor for breast carcinoma, not limited to the papillary type. The absence of PIK3CA mutations and presence of CNAs in IDP could be used clinically to identify patients at high risk of progression to carcinoma.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article